A brain trauma?Alzheimer’s disease connection
Nature Medicine
March 16, 2009
Two enzymes implicated in Alzheimer’s disease may also have a role in traumatic brain injury, according to research online this week in Nature Medicine.
Amyloid-beta peptides, pathological hallmarks of Alzheimer’s disease, accumulate rapidly after traumatic brain injury in humans. Mark Burns and his colleagues now show that blocking either beta- or gamma-secretase, enzymes required for production of Amyloid-beta, can reduce deficits in movement and behavior and reduce neuronal loss after experimentally inflicted brain injury in mice.
The authors propose that these two secretases, which are being actively pursued in the fight against Alzheimer’s disease, could also be promising targets to treat traumatic brain injury.
doi: 10.1038/nm.1940
Research highlights
-
Oct 24
Health: High salt intake linked to cognitive decline in miceNature
-
Oct 24
Neuroscience: Microbes modify memory learning in miceNature
-
Oct 22
Evolution: The yeast makes the beerNature Ecology & Evolution
-
Oct 22
Genetics: Socioeconomic migration is linked to genetic differences in Great BritainNature Human Behaviour
-
Oct 22
Psychology: Doctors’ beliefs influence patients’ painNature Human Behaviour
-
Oct 22
A nutritional memory effect counteracts the benefits of dietary restriction in old miceNature Metabolism
